343 related articles for article (PubMed ID: 25545706)
1. Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure.
Rengo G; Pagano G; Paolillo S; de Lucia C; Femminella GD; Liccardo D; Cannavo A; Formisano R; Petraglia L; Komici K; Rengo F; Trimarco B; Ferrara N; Leosco D; Perrone-Filardi P
Eur J Clin Invest; 2015 Feb; 45(2):187-95. PubMed ID: 25545706
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure.
Rengo G; Pagano G; Filardi PP; Femminella GD; Parisi V; Cannavo A; Liccardo D; Komici K; Gambino G; D'Amico ML; de Lucia C; Paolillo S; Trimarco B; Vitale DF; Ferrara N; Koch WJ; Leosco D
Circ Res; 2016 Apr; 118(7):1116-24. PubMed ID: 26884616
[TBL] [Abstract][Full Text] [Related]
3. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
[TBL] [Abstract][Full Text] [Related]
4. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
[TBL] [Abstract][Full Text] [Related]
5. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure.
Iaccarino G; Barbato E; Cipolletta E; De Amicis V; Margulies KB; Leosco D; Trimarco B; Koch WJ
Eur Heart J; 2005 Sep; 26(17):1752-8. PubMed ID: 16055494
[TBL] [Abstract][Full Text] [Related]
6. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
Rengo G; Lymperopoulos A; Zincarelli C; Femminella G; Liccardo D; Pagano G; de Lucia C; Cannavo A; Gargiulo P; Ferrara N; Perrone Filardi P; Koch W; Leosco D
Br J Pharmacol; 2012 Aug; 166(8):2430-40. PubMed ID: 22519418
[TBL] [Abstract][Full Text] [Related]
7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
8. [Lymphocyte GRK2 expression of the very elderly with chronic heart failure].
Gao WQ; Ma JL; Han CG; Wang Q; Zhu P; Yang TS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 May; 26(2):207-9. PubMed ID: 20684281
[TBL] [Abstract][Full Text] [Related]
9. GRK2 inhibition in heart failure: something old, something new.
Lymperopoulos A; Rengo G; Koch WJ
Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
[TBL] [Abstract][Full Text] [Related]
10. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
11. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support.
Akhter SA; D'Souza KM; Malhotra R; Staron ML; Valeroso TB; Fedson SE; Anderson AS; Raman J; Jeevanandam V
J Heart Lung Transplant; 2010 Jun; 29(6):603-9. PubMed ID: 20202864
[TBL] [Abstract][Full Text] [Related]
12. Old markers, new approach to assessment of risk in heart failure.
Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
[TBL] [Abstract][Full Text] [Related]
13. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.
Rengo G; Leosco D; Zincarelli C; Marchese M; Corbi G; Liccardo D; Filippelli A; Ferrara N; Lisanti MP; Koch WJ; Lymperopoulos A
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2032-8. PubMed ID: 20304818
[TBL] [Abstract][Full Text] [Related]
14. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
15. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
17. SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace.
Boffa U; McGrady M; Reid CM; Shiel L; Wolfe R; Liew D; Campbell DJ; Stewart S; Krum H
Aust Health Rev; 2017 May; 41(2):121-126. PubMed ID: 27096227
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
[TBL] [Abstract][Full Text] [Related]
19. Clinical and echocardiographic characteristics of elderly hospitalized patients with high levels of NT-proBNP without clinical diagnosis of heart failure.
Lelli D; Pedone C; Rossi FF; Incalzi RA
Aging Clin Exp Res; 2014 Dec; 26(6):607-13. PubMed ID: 24781829
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
